Zambon is an Italian pharmaceutical company known for its commitment to developing innovative treatments. It was founded in 1906 by Gaetano Zambon in Vicenza, Italy. Over the years, Zambon has expanded its operations globally and has established a strong presence in the pharmaceutical industry.

The company's headquarters are located in Bresso, in the province of Milan, Italy. This modern facility serves as the central hub for Zambon's operations and houses a team of skilled professionals dedicated to the company's research, development, production, and marketing activities. Zambon's product portfolio consists of a wide range of prescription and over-the-counter medications encompassing various therapeutic areas.

The company focuses on four core areas: respiratory, women's health, central nervous system, and special care. On a global scale, Zambon operates through a network of subsidiaries, joint ventures, and partnerships. Notably, the company has subsidiaries in Germany, France, Spain, the United Kingdom, and Brazil.

These subsidiaries play a vital role in expanding Zambon's presence in their respective markets while maintaining the company's high standards of quality and innovation. Zambon has achieved a strong market position, particularly in respiratory treatments. It has become a trusted name among healthcare professionals and patients alike.

The company's global sales have steadily increased over the years, driven by its dedication to research and development and its focus on delivering effective and reliable medications. In recent years, Zambon has made notable achievements and changes to strengthen its brand and product lineup. It has successfully introduced new treatments and expanded its presence in emerging markets.

Additionally, the company has actively pursued partnerships and collaborations to enhance its capabilities and reach. As of the latest available information, Zambon continues to thrive as a leading pharmaceutical company. It remains committed to developing innovative solutions to address unmet medical needs and improve patients' lives.

The company's dedication to scientific research and its global expansion efforts position it for continued growth and success in the future